stockrowDolby Laboratories
DLB Industrials Specialty Business Services
Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.
- Revenue
- −3.34%
- EPS
- −37.5%
- Free cash flow
- +157.4%
Quarter to June 2026, against a year earlier
Follow DLB
Alert me
Dolby Laboratories (DLB) EPS (diluted)
Dolby Laboratories's EPS (diluted) for fiscal 2025 was $2.62, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $2.35. Over the past ten years it has ranged from $0.40 (fiscal 2018) to $2.97 (fiscal 2021); the current reading is higher than 82% of that period. Dolby Laboratories ranks 10th of 34 Specialty Business Services companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $2.62 | (2.60%) |
| FY2024 | $2.69 | 31.22% |
| FY2023 | $2.05 | 13.26% |
| FY2022 | $1.81 | (39.06%) |
| FY2021 | $2.97 | 32.00% |
| FY2020 | $2.25 | (7.79%) |
| FY2019 | $2.44 | 516.94% |
| FY2018 | $0.40 | (79.72%) |
| FY2017 | $1.95 | 7.73% |
| FY2016 | $1.81 | 4.62% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $0.30 | (69.70%) |
| Mar 2026 | $0.99 | 80.00% |
| Dec 2025 | $0.55 | 7.84% |
| Sep 2025 | $0.51 | 6.25% |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| MMS Maximus, Inc. compare | $6.77 |
| UNF Unifirst Corporation compare | $6.01 |
| AZZ AZZ Inc. compare | $5.55 |
| ABM ABM Industries Incorporated compare | $2.77 |
| DLB Dolby Laboratories | $2.35 |
| CBZ CBIZ, Inc. compare | $2.13 |
| AMTM Amentum Holdings, Inc. compare | $0.83 |
| FA First Advantage Corporation compare | $0.14 |
| RTO Rentokil Initial PLC compare | — |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on DLB
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement